Flexibility of PCNA-protein interface accommodates differential binding partners

PLoS One. 2014 Jul 18;9(7):e102481. doi: 10.1371/journal.pone.0102481. eCollection 2014.

Abstract

The expanding roles of PCNA in functional assembly of DNA replication and repair complexes motivated investigation of the structural and dynamic properties guiding specificity of PCNA-protein interactions. A series of biochemical and computational analyses were combined to evaluate the PIP Box recognition features impacting complex formation. The results indicate subtle differences in topological and molecular descriptors distinguishing both affinity and stoichiometry of binding among PCNA-peptide complexes through cooperative effects. These features were validated using peptide mimics of p85α and Akt, two previously unreported PCNA binding partners. This study characterizes for the first time a reverse PIP Box interaction with PCNA. Small molecule ligand binding at the PIP Box interaction site confirmed the adaptive nature of the protein in dictating overall shape and implicates allosterism in transmitting biological effects.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Amino Acid Motifs
  • Binding Sites
  • Class Ia Phosphatidylinositol 3-Kinase / chemistry
  • Class Ia Phosphatidylinositol 3-Kinase / metabolism
  • Consensus Sequence
  • Crystallography, X-Ray
  • Fluorescence Polarization
  • Humans
  • Ligands
  • Models, Molecular
  • Molecular Dynamics Simulation
  • Peptides / chemistry
  • Peptides / metabolism
  • Proliferating Cell Nuclear Antigen / chemistry
  • Proliferating Cell Nuclear Antigen / metabolism*
  • Protein Binding
  • Protein Conformation
  • Protein Interaction Mapping
  • Proto-Oncogene Proteins c-akt / chemistry
  • Proto-Oncogene Proteins c-akt / metabolism
  • Recombinant Fusion Proteins / metabolism

Substances

  • Ligands
  • Peptides
  • Proliferating Cell Nuclear Antigen
  • Recombinant Fusion Proteins
  • Class Ia Phosphatidylinositol 3-Kinase
  • AKT1 protein, human
  • Proto-Oncogene Proteins c-akt

Grants and funding

This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Breast Cancer Research Program under Award No. W81XWH-10-1-0105 (VJD) and No. W81XWH-11-1-0050 (AMP). The cost of publication was covered by the Purdue Center for Cancer Research. The opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.